Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | News item

No adverse outcomes after methotrexate use by men preconception

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Although studies have shown no adverse pregnancy outcomes or adverse effects on the child after methotrexate use by men within 3 months prior to conception, as a precaution, the package leaflet for methotrexate still recommends the use of contraception when men are receiving methotrexate, says the Netherlands Pharmacovigilance Center, Lareb. …
Metadaten
Titel
No adverse outcomes after methotrexate use by men preconception
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41676-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ascorbic-acid

Case report

Lenalidomide

Case report

Multiple drugs

Case report

Chlorpromazine

Case report

Multiple drugs

Case report

Multiple drugs